Katja Petzold is studying how small molecules, microRNAs, are able to adapt their structure according to their environment so they can control messenger RNA when they transfer information to the proteins to be formed. She and her collaborators are also studying how these tiny molecules can regulate brain development.
In current cancer treatment it can take weeks or months before doctors know whether a drug is working on a patient. The methods that Kallioniemi’s team is developing are intended to enable the care team to understand what is happening in the patient’s cells, even while treatment is still in progress.
Researchers in Lund and Zurich are now developing methods to study the interaction between antibodies and bacteria in detail.
Artificial intelligence (AI) and quantum technology will change science, industry, healthcare and probably all sectors of society. They will undoubtedly affect our everyday lives. No one knows yet how revolutionary these developments will be, but we can agree here in Sweden that our nation needs to keep up with them.